SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-001080
Filing Date
2020-01-15
Accepted
2020-01-15 16:00:24
Documents
5
Period of Report
2020-01-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k011020_bioxytraninc.htm 8-K 30574
2 SECURITIES PURCHASE AGREEMENT BETWEEN EMA FINANCIAL LLC AND BIOXYTRAN, INC., DAT f8k011020ex10-44_bioxytran.htm EX-10.44 99431
3 4% CONVERTIBLE NOTE OF BIOXYTRAN, INC. TO EMA FINANCIAL LLC. IN THE PRINCIPAL AM f8k011020ex10-45_bioxytran.htm EX-10.45 130604
4 WARRANT TO PURCHASE 50,000 SHARES OF COMMON STOCK OF BIOXYTRAN f8k011020ex10-46_bioxytran.htm EX-10.46 72874
5 GRAPHIC ex10-4_001.jpg GRAPHIC 3337
  Complete submission text file 0001213900-20-001080.txt   339756
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 20528302
SIC: 2834 Pharmaceutical Preparations